Stock screener

SPRY

Conviction 0HealthcareScan · Thu, Sep 24, 2026
Dragonfly doji

ARS Pharmaceuticals, Inc. (SPRY) closed at $4.16 (-0.48%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 6, -68.2% from its 52-week high, -63.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SPRY$4.16-0.48%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.57M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ARS Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.ars-pharma.com ↗
Price4.16
Change-0.48%
Gap-0.48%
Rel volume0.98×
Avg volume1.5M
Avg $ vol7.29M
SMA 204.98
SMA 505.55
SMA 2008.29
Price vs 50-25.02%
Price vs 200-49.85%
MA stackbearish
50/200 cross—
Supertrenddown · 4.96
RSI (14)31
MACD hist-0.04
MACD cross—
Stoch %K / %D6 / 11
ADX (14)37
+DI / −DI16 / 39
RSI divergence—
MACD divergence—
ATR %7.29%
ADR %5.34%
52w high13.06
52w low4.11
From 52w high-68.15%
Above 52w low+1.22%
New 52w highNo
SqueezeOff
Bollinger width57.66%
%B0.21
Donchian pos4.39%
Donchian high6.12
Donchian low4.07
AVWAP (52w high)7.77
vs AVWAP high-46.46%
AVWAP (52w low)4.28
vs AVWAP low-2.77%
OBV trendDown
Chaikin MF (20)-0.39
Today vs 20d0.98×
Avg vol (14d)1.57M
Avg vol (20d)1.5M
Avg $ vol (20d)7.29M
Market cap413.7M
RS Rating6 / 99
RS 3m (vs SPY)-52.62%
RS 6m (vs SPY)-64.16%
RS line new highNo
Trend template0/8
Technical rank6.4
1 week+0.24%
1 month-27.27%
3 months-48.13%
6 months-47.34%
1 year-58.15%
YTD-63.79%
P/E-2.42
P/B33.06
P/S4.91
P/FCF-2.42
EPS-1.74
Div yield—
ROE—
ROA-68.66%
Debt/Eq7.73
Current3.48
EV/EBITDA-2.80
Gross margin—
Net margin-203.25%
Rev growth-5.46%
EPS growth-2241.76%
Price target22.50
Target upside440.87%
Analyst ratingBuy
Institutional94.69%
Ent. value502.21M
Revenue33.66M
Net income-62.34M
Gross profit—
Free cash flow-171.21M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out99.3M
Employees159
ListedWed, Nov 9, 2022
Free float36.1M
Float %36.4%
Short interest23.21M
Days to cover14.1d
Short volume70.0%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.63 vs −$0.55
Last surprise-14.6% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank6.4 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SPRY

All disclosures →
No recent disclosed trades by Congress in SPRY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPRY

InsiderSideShares
Smith Margaret Ekins
Chief Commercial Officer · Stock Option (right to buy) · 2026-09-01
Grant1M
SCHNEIDER PHILLIP M
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
RA CAPITAL MANAGEMENT, L.P.
Director · Stock Option (Right to Buy) · 2026-06-24
Grant30K
SAUNDERS BRENT L
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Islam Saqib
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Shah Pratik
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Kelly Michael
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Dadoo Rajeev
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Shawver Laura
Director · Stock Option (right to buy) · 2026-06-24
Grant30K
Thompson Peter A.
Director · Stock Option (right to buy) · 2026-06-24
Grant30K

SEC filings

EDGAR filings in SPRY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.